Seahorse XF96 Extracellular Flux Analyzer
Seahorse XF96 Extracellular Flux Analyzer
批准号:
8447968
负责人:
Enrique Saez
金额:
$17.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-27 至 2014-06-26
关键词:
AdipocytesAgingBioenergeticsBiological AssayCaloric RestrictionCardiac MyocytesCardiovascular DiseasesCell CountCell RespirationCellsCoupledDevelopmentDiseaseElementsEnvironmentEnzymesEvaluationFundingGenetic ModelsGenus HippocampusGlycolysisGrowthHealthHepatocyteHomeostasisHumanInjection of therapeutic agentInsulin ResistanceMalignant NeoplasmsMeasurementMeasuresMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMitochondriaModelingMonitorMusMuscle FibersMutationNeurodegenerative DisordersNeuronsNon-Insulin-Dependent Diabetes MellitusNutrientOrganismOxidative PhosphorylationOxygen ConsumptionPathogenesisPathologic ProcessesPhysical activityPhysiologicalPhysiological ProcessesPreclinical Drug EvaluationProtein-Folding DiseaseResearchResearch PersonnelResistance developmentRespirationSignal TransductionTechnologyTimecancer cellextracellularfatty acid oxidationinhibitor/antagonistinsightinstrumentmitochondrial dysfunctionrespiratoryresponse
中文摘要
产品说明:我们正在申请资金购买Seahorse XF 96细胞外通量分析仪,这是一种在几分钟内以中/高通量方式非侵入性地分析细胞代谢活性和生物能量状态的仪器。Seahorse XF 96胞外通量分析仪采用简单的微孔板格式,可真实的实时同时测量耗氧量(细胞呼吸)和胞外酸化率。结合使用不同的能量底物和特定酶和代谢途径的各种抑制剂,可以通过四个集成的注射端口自动输送,Seahorse细胞外通量分析仪提供了前所未有的,彻底和快速的氧化磷酸化,糖酵解,营养利用,脂肪酸氧化,耦合与非耦合呼吸,以及细胞的备用呼吸能力的评估。目前没有其他单一仪器可以在96孔格式中执行相同范围的代谢测定。线粒体功能和适当的底物利用是对人类健康重要的大多数生理过程的核心,包括生长、能量稳态、体力活动能力和衰老。线粒体功能障碍涉及多种疾病的起始、发展和/或发病机制,包括代谢疾病(例如胰岛素抵抗和2型糖尿病的发展)、癌症、神经变性疾病和心血管疾病。申请的Seahorse XF 96细胞外通量分析仪将使至少12名目前无法获得类似仪器或技术的研究人员能够深入了解用于模拟生理和病理过程的各种细胞和生物体的细胞代谢(包括原代肝细胞、脂肪细胞、神经元、心肌细胞、癌细胞、肌管和蠕虫)。Seahorse XF 96细胞外通量分析仪的关键元素使其非常适合用户的特定需求,仪器能够:1)监测附着的细胞(神经元、脂肪细胞、肝细胞和肌管的关键考虑因素,12名研究者中有7名使用); 2)从少量细胞获得可靠的测量(对于从小鼠遗传模型中获得原代细胞的6个用户至关重要;和3)提供中/高通量形式,从而能够进行药物筛选(5个项目)和评估对广泛的生理信号、环境损伤和遗传改变的反应(对所有项目都很重要)。Seahorse XF 96细胞外通量分析仪在功能组合方面无与伦比,非常适合当前用户的研究。仪器将放置在适合多用户的环境中,所有用户均可随时访问,新用户也可使用。总之,通过提供细胞代谢和线粒体功能的全面评估,Seahorse XF 96胞外通量分析仪将促进和加强我们对代谢和代谢疾病,癌症,神经退行性疾病,衰老,热量限制和蛋白质折叠疾病的研究。
英文摘要
DESCRIPTION: We are requesting funds to purchase a Seahorse XF96 Extracellular Flux Analyzer, an instrument that profiles the metabolic activity and bioenergetic state of cells non-invasively, in minutes, and in a medium/high- throughput manner. The Seahorse XF96 Extracellular Flux Analyzer uses a simple microplate format to simultaneously measure oxygen consumption (cellular respiration) and extracellular acidification rates, in real time. Combined with the use of different substrates for energy and various inhibitors of specific enzymes and metabolic pathways, which can be delivered automatically via four integrated injection ports, the Seahorse Extracellular Flux Analyzer provides an unprecedented, thorough and fast assessment of oxidative phosphorylation, glycolysis, nutrient utilization, fatty acid oxidation, coupled vs. uncoupled respiration, and spare respiratory capacity of cells. There is currently no other single instrument that can perform the same range of metabolic assays in a 96-well format. Mitochondria function and proper substrate utilization are central to most physiologic processes important for human health, including growth, energy homeostasis, capacity for physical activity, and aging. Mitochondrial dysfunction has been implicated in the initiation, development and/or pathogenesis of a wide variety of diseases, including metabolic diseases (e.g. insulin resistance and development of type 2 diabetes), cancer, neurodegenerative diseases, and cardiovascular disease. The requested Seahorse XF96 Extracellular Flux Analyzer will enable a minimum of 12 investigators, which currently have no access to a similar instrument or technology, to gain insights into the cellular metabolism of a wide range of cells and organisms used to model physiological and pathological processes (including primary hepatocytes, adipocytes, neurons, cardiomyocytes, cancer cells, myotubes, and worms). The key elements of the Seahorse XF96 Extracellular Flux Analyzer that make it ideally suited for the specific needs of the users are the ability of the instrument to: 1) monitor attached cells (a crucial consideration for neurons, adipocytes, hepatocytes, and myotubes, used by 7 of 12 investigators); 2) obtain reliable measurements from small numbers of cells (crucial for 6 users that derive primary cells from mouse genetic models; and, 3) offer a medium/high throughput format, thereby enabling drug screening (5 projects) and evaluation of responses to a wide range of physiologic signals, environmental insults, and genetic alterations (important for all projects). The Seahorse XF96 Extracellular Flux Analyzer is unsurpassed in the combination of features that make it ideally suited to the studies of the current users. The instrument will be placed in a multi-user appropriate environment, readily accessible to all users, and available to new users. In summary, by providing a comprehensive assessment of cellular metabolism and mitochondrial function, the Seahorse XF96 Extracellular Flux Analyzer will facilitate and enhance our research on metabolism and metabolic diseases, cancer, neurodegenerative diseases, aging, calorie restriction, and diseases of protein folding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Heme Homeostasis on Adipocyte Function
-
批准号:10398012
-
项目类别:
-
资助金额:$50.87万
-
财政年份:2019
-
负责人:Enrique Saez
-
依托单位:
Impact of Heme Homeostasis on Adipocyte Function
-
批准号:9975170
-
项目类别:
-
资助金额:$52.87万
-
财政年份:2019
-
负责人:Enrique Saez
-
依托单位:
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia
-
批准号:8571857
-
项目类别:
-
资助金额:$24.73万
-
财政年份:2013
-
负责人:Enrique Saez
-
依托单位:
Targeting Adipocyte Lipases to Treat Pancreatic Cancer-Associated Cachexia
-
批准号:8708010
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2013
-
负责人:Enrique Saez
-
依托单位:
A Genome-wide RNAi Screening Platform for the Common Lab
-
批准号:8310233
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:Enrique Saez
-
依托单位:
A Genome-wide RNAi Screening Platform for the Common Lab
-
批准号:8111236
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:Enrique Saez
-
依托单位:
A Genome-wide RNAi Screening Platform for the Common Lab
-
批准号:7900849
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2009
-
负责人:Enrique Saez
-
依托单位:
Nuclear Receptor Control of Glucose and Lipid Metabolism
-
批准号:7582268
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2008
-
负责人:Enrique Saez
-
依托单位:
Nuclear Receptor Control of Glucose and Lipid Metabolism
-
批准号:7781343
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2008
-
负责人:Enrique Saez
-
依托单位:
Nuclear Receptor Control of Glucose and Lipid Metabolism
-
批准号:8055439
-
项目类别:
-
资助金额:$37.15万
-
财政年份:2008
-
负责人:Enrique Saez
-
依托单位:
Nuclear Receptor Control of Glucose and Lipid Metabolism
-
批准号:8248284
-
项目类别:
-
资助金额:$37.15万
-
财政年份:2008
-
负责人:Enrique Saez
-
依托单位:
海外基金